This week, we hear about ISMPP’s assumption of MPIP leadership and find out how the COVID-19 pandemic influenced scientific collaboration and publication in 2020. We explore certain concerns that the Plan S mandate could derail the ambition of improving access to scientific communication. We also look at the new guidelines for trials involving AI and how the Royal Society of Chemistry is leading the way in increasing diversity in publishing. Finally, we see that, despite tough times, there is still a strong community of volunteers working away to improve the landscape of scholarly publication.
Weekly digest: what’s happening in open science?
Happy New Year! On the theme of new, this week, we look at a new rule on data transparency from the US Environmental Protection Agency, the new Enhanced Publication Options Navigator from MPIP, Wiley’s new acquisition of open access publisher Hindawi and a new community platform from eLife. We also learn about the impact of open access on sustainable development goals and get a primer on open access from Science.
Weekly digest: what’s happening in open science?
This week, we hear from cOAlition S about green open access and feature announcements from Elsevier and the Dutch Research Council. We also look at what kinds of manuscripts should be deposited on preprint servers – and what kinds should be removed. Finally, we learn about publishing networks that streamline the publication process.
Weekly digest: what’s happening in open science?
This week, we look at the effect of the COVID-19 pandemic on library budgets as well as two important announcements from eLife and PLOS ONE. We also learn how smaller publishers can transition to open access models of publishing. Finally, we consider a different perspective on green open access.
Weekly digest: what’s happening in open science?
This week, we look at the fallout from Springer Nature’s most recent open access announcement as well as Emerald Publishing’s commitment to open abstracts and the Open Access Scholarly Publishing Association’s online conference sessions. We also share advice on how to write a plain language summary and on how to stay relevant in the rapidly changing world of scholarly publishing. Finally, we hear the Editor-in-Chief of Nature’s thoughts on open access.
Weekly digest: what’s happening in open science?
This week, we explore how academics have been spending their time during the COVID-19 pandemic and the impact this is having on scholarly publishing now and in the future. We also look at the report from the 8th EMWA Symposium. Finally, we ‘Poké’ a bit of fun at predatory journals.
Weekly digest: what’s happening in open science?
This week, we explore the importance of data sharing in COVID-19, Alzheimer’s disease and social psychology research. We also look at trends in open access publishing across the globe and focus on open access initiatives in Africa. Finally, we learn the ideal frequency for the word ‘and’.
Weekly digest: what’s happening in open science?
Featuring new FDA guidance on diversity and inclusion in clinical trials, further calls for COVID-19 vaccine clinical trial transparency, how the UN is promoting open science, discussions on the evolving ecosystem of scientific publishing and two recent analyses of predatory journal watch lists.
Weekly digest: what’s happening in open science?
Featuring a rundown of the latest results from EU Trials Tracker, how pharma could help make vaccine clinical trials trustworthy again, a survey of researchers’ attitudes towards peer reviewing, the citation advantage of preprints, the next consortium to commit to open science and a reminder of the EMWA virtual events.
Weekly digest: what’s happening in open science?
Featuring the upcoming EMWA Virtual Conference, Open Pharma’s new open access advocacy resource, a joint appeal for open science, reflections on equitable scholarly communications, an example of a journal switching from hybrid to full open access and ideas on how to improve discoverability.